Abstract
Resveratrol is a plant polyphenolic compound. Evidence indicates that resveratrol has beneficial effects against aging and neurodegenerative diseases. The goal of our study was in vivo examination of the effects of resveratrol on the abundance of mRNA encoding Brain Derived Neurotrophic Factor (BDNF) in the hippocampus of rat brain. Rats were administrated orally by different doses (2.5–20 mg/kg bwt) of resveratrol for 3, 10 and 30 days. Saline was used as control and 10% ethanol in saline was used as vehicle for resveratrol. Measurement of BDNF mRNA by Real-time RT–PCR showed that levels of the mRNA for BDNF were significantly and dose dependently elevated in the hippocampal tissues of rats. The findings suggest that the neuroprotective effects of resveratrol may be at least partly due to its inducing effects on the expression levels of the BDNF mRNA.
Similar content being viewed by others
References
Harikumar KB, Aggarwal BB (2008) Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle 7:1020–1035
Mokni M, Elkahoui S, Limam F, Amri M, Aouani E (2007) Effect of resveratrol on antioxidant enzyme activities in the brain of healthy rat. Neurochem Res 32:981–987
Han YS, Bastianetto S, Dumont Y, Quirion R (2006) Specific plasma membrane binding sites for polyphenols, including resveratrol, in the rat brain. J Pharmacol Exp Ther 318:238–245
Pallas M, Casadesus G, Smith MA, Coto-Montes A, Pelegri C, Vilaplana J, Camins A (2009) Resveratrol and neurodegenerative diseases: activation of sirt1 as the potential pathway towards neuroprotection. Curr Neurovasc Res 6:70–81
Zhang F, Liu J, Shi JS (2010) Anti-inflammatory activities of resveratrol in the brain: role of resveratrol in microglial activation. Eur J Pharmacol 636:1–7
Cohen-Cory S, Kidane AH, Shirkey NJ, Marshak S (2010) Brain-derived neurotrophic factor and the development of structural neuronal connectivity. Dev Neurobiol 70:271–288
Numakawa T, Suzuki S, Kumamaru E, Adachi N, Richards M, Kunugi H (2010) Bdnf function and intracellular signaling in neurons. Histol Histopathol 25:237–258
Tyler WJ, Pozzo-Miller LD (2001) Bdnf enhances quantal neurotransmitter release and increases the number of docked vesicles at the active zones of hippocampal excitatory synapses. J Neurosci 21:4249–4258
Pardon MC (2010) Role of neurotrophic factors in behavioral processes: implications for the treatment of psychiatric and neurodegenerative disorders. Vitam Horm 82:185–200
Pezet S, Malcangio M (2004) Brain-derived neurotrophic factor as a drug target for cns disorders. Expert Opin Ther Targets 8:391–399
Takuma K, Matsuo A, Himeno Y, Hoshina Y, Ohno Y, Funatsu Y, Arai S, Kamei H, Mizoguchi H, Nagai T, Koike K, Inoue M, Yamada K (2007) 17beta-estradiol attenuates hippocampal neuronal loss and cognitive dysfunction induced by chronic restraint stress in ovariectomized rats. Neuroscience 146:60–68
Zou J, Crews F (2006) Creb and nf-kappab transcription factors regulate sensitivity to excitotoxic and oxidative stress induced neuronal cell death. Cell Mol Neurobiol 26:385–405
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative pcr and the 2(-delta delta c(t)) method. Methods 25:402–408
Williamson G, Manach C (2005) Bioavailability and bioefficacy of polyphenols in humans. Ii. Review of 93 intervention studies. Am J Clin Nutr 81:243S–255S
Davis MI (2008) Ethanol-bdnf interactions: still more questions than answers. Pharmacol Ther 118:36–57
Tapia-Arancibia L, Rage F, Givalois L, Dingeon P, Arancibia S, Beauge F (2001) Effects of alcohol on brain-derived neurotrophic factor mrna expression in discrete regions of the rat hippocampus and hypothalamus. J Neurosci Res 63:200–208
Miller R, King MA, Heaton MB, Walker DW (2002) The effects of chronic ethanol consumption on neurotrophins and their receptors in the rat hippocampus and basal forebrain. Brain Res 950:137–147
Okamoto H, Miki T, Lee KY, Yokoyama T, Kuma H, Gu H, Li HP, Matsumoto Y, Yamaoka I, Fusumada K, Imagawa T, Wang ZY, Nakamura Y, Takeuchi Y (2006) Effects of chronic ethanol administration on the expression levels of neurotrophic factors in the rat hippocampus. Okajimas Folia Anat Jpn 83:1–6
Marambaud P, Zhao H, Davies P (2005) Resveratrol promotes clearance of alzheimer’s disease amyloid-beta peptides. J Biol Chem 280:37377–37382
Vingtdeux V, Dreses-Werringloer U, Zhao H, Davies P, Marambaud P (2008) Therapeutic potential of resveratrol in alzheimer’s disease. BMC Neurosci 9(Suppl 2):S6
Savaskan E, Olivieri G, Meier F, Seifritz E, Wirz-Justice A, Muller-Spahn F (2003) Red wine ingredient resveratrol protects from beta-amyloid neurotoxicity. Gerontology 49:380–383
Queen BL, Tollefsbol TO (2010) Polyphenols and aging. Curr Aging Sci 3:34–42
Camins A, Sureda FX, Junyent F, Verdaguer E, Folch J, Beas-Zarate C, Pallas M (2010) An overview of investigational antiapoptotic drugs with potential application for the treatment of neurodegenerative disorders. Expert Opin Investig Drugs 19:587–604
Darvesh AS, Carroll RT, Bishayee A, Geldenhuys WJ, Van der Schyf CJ (2010) Oxidative stress and alzheimer’s disease: dietary polyphenols as potential therapeutic agents. Expert Rev Neurother 10:729–745
Wu D (2005) Neuroprotection in experimental stroke with targeted neurotrophins. NeuroRx 2:120–128
Ford GA, Bryant CA, Mangoni AA, Jackson SH (2004) Stroke, dementia, and drug delivery. Br J Clin Pharmacol 57:15–26
Weinreb O, Amit T, Bar-Am O, Youdim MB (2007) Induction of neurotrophic factors gdnf and bdnf associated with the mechanism of neurorescue action of rasagiline and ladostigil: new insights and implications for therapy. Ann N Y Acad Sci 1122:155–16828
Ochs G, Penn RD, York M, Giess R, Beck M, Tonn J, Haigh J, Malta E, Traub M, Sendtner M, Toyka KV (2000) A phase i/ii trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:201–206
(1999) A controlled trial of recombinant methionyl human bdnf in als: the bdnf study group (phase iii). Neurology 52:1427–1433
Pardridge WM, Kang YS, Buciak JL (1994) Transport of human recombinant brain-derived neurotrophic factor (bdnf) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery. Pharm Res 11:738–746
Kishino A, Katayama N, Ishige Y, Yamamoto Y, Ogo H, Tatsuno T, Mine T, Noguchi H, Nakayama C (2001) Analysis of effects and pharmacokinetics of subcutaneously administered bdnf. Neuroreport 12:1067–1072
Acknowledgments
This paper has been extracted from the M.Sc. thesis of Mostafa Rahvar and was supported by Grant Number 3492 from Medicinal and Natural Products Chemistry Research Center—Vice-chancellor for Research Affairs of Shiraz University of Medical Sciences. We acknowledge the cooperation of Hematology research center as well as Dr Nader Tanideh from Stem Cell and Transgenic Technology Research Center, Shiraz University of Medical Sciences, Shiraz-Iran.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rahvar, M., Nikseresht, M., Shafiee, S.M. et al. Effect of Oral Resveratrol on the BDNF Gene Expression in the Hippocampus of the Rat Brain. Neurochem Res 36, 761–765 (2011). https://doi.org/10.1007/s11064-010-0396-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-010-0396-8